Allarity Therapeutics, Inc. Purchase Agreements
11 Contracts & Agreements
- Form of Securities Purchase Agreement between the Company and the investors thereto, dated August 19, 2024 (Filed With SEC on August 21, 2024)
- Amendment to Securities Purchase Agreement, dated as of January 25, 2024, by and between the Company and the Purchaser listed on the signature page attached thereto (Filed With SEC on January 25, 2024)
- Securities Purchase Agreement, dated as of January 18, 2024, by and between the Company and the Purchaser listed on the signature page attached thereto (Filed With SEC on January 19, 2024)
- Form of Securities Purchase Agreement (Filed With SEC on December 5, 2023)
- Form of Securities Purchase Agreement (Filed With SEC on June 30, 2023)
- Securities Purchase Agreement (Filed With SEC on April 25, 2023)
- Form of Securities Purchase Agreement (Filed With SEC on March 28, 2023)
- Form of Securities Purchase Agreement (Filed With SEC on February 28, 2023)
- Asset Purchase Agreement dated December 17, 2021, between Allarity Therapeutics A/S, Allarity Therapeutics, Inc. and Allarity Acquisition Subsidiary Inc (Filed With SEC on December 22, 2021)
- Asset Purchase Agreement dated July 23, 2021 between Allarity Therapeutics A/S and Lantern Pharma Inc (Filed With SEC on August 20, 2021)
- Securities Purchase Agreement dated May 20, 2021 between Allarity Therapeutics, Inc. and 3i, LLP (Filed With SEC on August 20, 2021)
